Akers Biosciences, Inc. (AKR) - Product Pipeline Analysis, 2015 Update

Date: September 29, 2015
Pages: 35
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AE26E4B21FDEN
Leaflet:

Download PDF Leaflet

Akers Biosciences, Inc. (AKR) - Product Pipeline Analysis, 2015 Update
Summary

Akers Biosciences, Inc. (ABI) is a medical device company that develops, manufactures and supplies rapid, point-of-care screening and testing products. The company offers products such as BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA Chlamydia, PIFA Dengue Fever, PIFA Malaria, PIFA Syphilis, PIFA Heparin, and breath ketone. It provides testing platform technologies that include MPC biosensor, particle immunofiltration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. The company also offers seraSTAT rapid blood cell separation, a sample preparation technology. ABI is headquartered in West Deptford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Akers Biosciences, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Akers Biosciences, Inc. Company Snapshot
Akers Biosciences, Inc. Company Overview
Key Information
Akers Biosciences, Inc. Pipeline Products and Clinical Trials Overview
Akers Biosciences, Inc. – Pipeline Analysis Overview
Key Facts
Akers Biosciences, Inc. - Major Products and Services
Akers Biosciences, Inc. Pipeline Products by Development Stage
Akers Biosciences, Inc. Pipeline Products Overview
Breath PulmoHealth Check - Asthma
Breath PulmoHealth Check - Asthma Product Overview
Breath PulmoHealth Check - COPD
Breath PulmoHealth Check - COPD Product Overview
Breath PulmoHealth Check - Lung Cancer
Breath PulmoHealth Check - Lung Cancer Product Overview
PIFA Hepatitis B
PIFA Hepatitis B Product Overview
PIFA Hepatitis C
PIFA Hepatitis C Product Overview
PIFA HIV 1+2 Rapid Assay
PIFA HIV 1+2 Rapid Assay Product Overview
PIFA PLUSS Chlamydia Rapid Assay
PIFA PLUSS Chlamydia Rapid Assay Product Overview
PIFA PLUSS Malaria Rapid Assay
PIFA PLUSS Malaria Rapid Assay Product Overview
PIFA Syphilis Rapid Assay
PIFA Syphilis Rapid Assay Product Overview
Akers Biosciences, Inc. - Key Competitors
Akers Biosciences, Inc. - Key Employees
Akers Biosciences, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Akers Biosciences, Inc., Recent Developments
Sep 14, 2015: Akers Biosciences Launches METRON - the First and Only Disposable Breath Ketone Test
Aug 18, 2015: Akers Biosciences Announces Q2 2015 Earnings
Jun 30, 2015: Akers Biosciences Appoints Former Congressman Rob Andrews to the Board
Jun 16, 2015: Akers Biosciences Updates on New Rapid Breath Ketone and Oxidative Stress Tests for Health and Wellness Industry
May 14, 2015: Akers Biosciences Announces Financial Results for First Quarter 2015
May 12, 2015: Akers Biosciences Introduces New Rapid Breath Oxidative Stress Tests to the Health and Wellness Industry
May 12, 2015: Akers Biosciences Introduces New Rapid Breath Ketone Stress Tests to the Health and Wellness Industry
Apr 13, 2015: Akers Biosciences Further Expands International Distribution Of Flagship Rapid Test
Apr 02, 2015: Akers Bio Signs Distribution Agreement With ADS for U.S. Govt.
Mar 23, 2015: Akers Biosciences Reports Earnings for Fiscal Year 2014
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Akers Biosciences, Inc., Key Facts
Akers Biosciences, Inc. Pipeline Products and Clinical Trials Overview
Akers Biosciences, Inc. Pipeline Products by Equipment Type
Akers Biosciences, Inc. Pipeline Products by Indication
Akers Biosciences, Inc., Key Facts
Akers Biosciences, Inc., Major Products and Services
Akers Biosciences, Inc. Number of Pipeline Products by Development Stage
Akers Biosciences, Inc. Pipeline Products Summary by Development Stage
Breath PulmoHealth Check - Asthma - Product Status
Breath PulmoHealth Check - Asthma - Product Description
Breath PulmoHealth Check - COPD - Product Status
Breath PulmoHealth Check - COPD - Product Description
Breath PulmoHealth Check - Lung Cancer - Product Status
Breath PulmoHealth Check - Lung Cancer - Product Description
PIFA Hepatitis B - Product Status
PIFA Hepatitis B - Product Description
PIFA Hepatitis C - Product Status
PIFA Hepatitis C - Product Description
PIFA HIV 1+2 Rapid Assay - Product Status
PIFA HIV 1+2 Rapid Assay - Product Description
PIFA PLUSS Chlamydia Rapid Assay - Product Status
PIFA PLUSS Chlamydia Rapid Assay - Product Description
PIFA PLUSS Malaria Rapid Assay - Product Status
PIFA PLUSS Malaria Rapid Assay - Product Description
PIFA Syphilis Rapid Assay - Product Status
PIFA Syphilis Rapid Assay - Product Description
Akers Biosciences, Inc., Key Employees
Akers Biosciences, Inc., Subsidiaries

LIST OF FIGURES

Akers Biosciences, Inc. Pipeline Products by Equipment Type
Akers Biosciences, Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

Akers Biosciences, Inc. (AKR) - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: